APITOPE
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Gravesโ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.
APITOPE
Industry:
Biotechnology Health Care Medical
Founded:
2002-01-01
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.apitope.com
Total Employee:
11+
Status:
Active
Total Funding:
22 M EUR
Technology used in webpage:
Person Schema Gravatar Profiles Gravity Forms British Server Location
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
SA Biotech
SA Biotech is a Healthcare company.
Current Employees Featured
Founder
Investors List
Limburgse Reconversie Maatschappij
Limburgse Reconversie Maatschappij investment in Series B - Apitope
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series B - Apitope
PMV Pharmaceuticals
PMV Pharmaceuticals investment in Series B - Apitope
Wyvern Seed Fund
Wyvern Seed Fund investment in Series B - Apitope
Arthurian Life Sciences
Arthurian Life Sciences investment in Series B - Apitope
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series A - Apitope
Vinnof
Vinnof investment in Series A - Apitope
Official Site Inspections
http://www.apitope.com
- Host name: 176-58-126-104.ip.linodeusercontent.com
- IP address: 176.58.126.104
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "Apitope"
Apitope - Crunchbase Company Profile & Funding
Sep 29, 2015 Apitope is a European biotech company. Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic โฆSee details»
Apitope Company Profile - Office Locations, Competitors ... - Craft
Apitope has 5 employees across 2 locations and $26.22 m in total funding,. See insights on Apitope including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Apitope - LinkedIn
Apitope | 1,510 followers on LinkedIn. Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis โฆSee details»
Apitope International N.V. - Life-Sciences-Europe.com
Jan 13, 2009 Apitope is a clinical stage biotech company that develops potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases.See details»
Apitope Company Profile 2024: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Apitope. Use the PitchBook Platform to explore the full profile.See details»
Apitope - LinkedIn
Apitope | 1,511 followers on LinkedIn. Apitope is a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapeutics targeting the immunological basis โฆSee details»
Apitope - VentureRadar
"Apitope International NV is a biopharmaceutical company with its head office in Diepenbeek, Belgium, and a subsidiary in Bristol, United Kingdom.See details»
Apitope CEO and Key Executive Team | Craft.co
Apitope's Chief Executive Officer is Hayley French. Other executives include Stéphane Verdood, Non-Executive Director; Chairman of the Board; Liselotte Jansson, Chief Research Officer and โฆSee details»
Apitope - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 29, 2015: Series B - โฆSee details»
Apitope International Company Profile | Diepenbeek, Belgium ...
Find company research, competitor information, contact details & financial data for Apitope International of Diepenbeek. Get the latest business insights from Dun & Bradstreet.See details»
Apitope - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Apitope is a European biotech company. Unlock even more features with Crunchbase ProSee details»
Apitope โ World-leading clinical-stage biotech firm, developing โฆ
October Edition 2020. Apitope โ World-leading clinical-stage biotech firm, developing antigen-specific immunotherapeutics for autoimmune diseasesSee details»
Worg Pharma to Acquire Apitope - BioVille
Expands immunotherapy pipeline with potential first in class treatments for a range of autoimmune diseases. Hangzhou, China and Diepenbeek, Belgium, (August 18, 2021): Worg โฆSee details»
Interview with Keith Martin, CEO, Apitope - pharmaboardroom.com
Apitopeโs research and success is based on its High Speed Technology Platform that uses solubleโฆSee details»
Apitope strengthens its board with new director - PMLiVE
Mar 22, 2018 Clinical stage biotech Apitope has appointed Dr William Jenkins as its independent, non-executive director to its board. Dr Jenkins has a wealth of pharmaceutical โฆSee details»
Home - Epitopea
Epitopea is a transatlantic cancer immunotherapeutics company based in Montreal, Canada and Cambridge, UK. Our proprietary CryptoMap TM platform, created and optimized by Drs. โฆSee details»
Worg Pharmaceuticals to Acquire Apitope International
Sep 29, 2021 Worg Pharmaceuticals to Acquire Apitope International Expands immunotherapy pipeline with potential first-in-class treatments for a range of autoimmune diseases Hangzhou, โฆSee details»
Rope Access Services Melbourne | API Rope Access
API Rope Access offers a wide range of rope access services in Melbourne. From caulking and water testing to recladding, builders clean to facade repairs, we offer a comprehensive range โฆSee details»
Epitopea - Crunchbase Company Profile & Funding
Epitopea is a transatlantic cancer immunotherapeutics company. Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by โฆSee details»
Rope Access Electrician | API Rope Access
Email: [email protected]. MICHELLE VASSALLO. Chief Finance Officer. Mobile: 0411 708 623 Email: [email protected]. Access Personnel International Pty Ltd is an industry leader in โฆSee details»